Trade of the Day

Publisher’s Note: Starting July 28, the Wake-Up Watchlist is going text-only through our free VIP alert list. If you’re not signed up by then, you’ll stop getting it. No exceptions.

You’ll get daily tickers sent straight to your phone, plus access to Wakeup Watchlist LIVE every Monday with Chris “CJ” Johnson breaking down the week’s top opportunities.<...

Humira did $21.2 billion in 2022. That was 37% of AbbVie’s entire revenue, and a few years before that, it was more than half the company.

Then the patents went. Ten biosimilars came at it, and everybody on Wall Street spent years explaining why AbbVie couldn’t possibly replace that. The previous record for a drug going off patent was Pfizer’s Lipitor at around $13 bil...

Healthcare ranked as the worst place to invest for three years. That’s over.

Nobody wanted this sector. Tech was eating everything, and every drug company on the board had the same cloud hanging over it — the government was about to negotiate their prices down, and nobody knew how bad it was going to get.

Then, on January 1, the first negotiated prices actually ...

Hey gang, Nate here.

Three stocks caught my eye this week. All three are sitting right at all-time highs. They have the exact bullish setup I look for.

And believe it or not, all three of them got downgraded the same day.

Give me a break.

You don’t downgrade a chart that looks like this.

Not unless you want your clients getting in cheap befo...

Publisher’s Note: Tomorrow at 2 pm ET, CJ is joined by special guest Matt McCall—one of Wall Street’s most respected innovation investors.

Fox Business’s Neil Cavuto once called Matt “one of my best guests” for his ability to cut through the noise and uncover opportunity before the crowd. For more than 25 years,

Matt has helped investors identif...